abstract |
The present invention relates to a novel process for preparing uracil derivatives useful as intermediates in the synthesis of uridines having antiviral or antitumor activity or useful as coadjuvants in antiviral therapy, characterized by converting a compound of formula (II) into its mesylate derivative of formula (III) which is the reduced to give the desired compound of formula (I), in which R1 is H, halogen, alkyl, aryl or aralkyl. |